Table 3.
Relative risk reduction (RRR, %) between treatments (teriparatide versus placebo) for morphometric vertebral fractures at different values of 10-year probability of hip fracture calculated without BMD, assuming no treatment
Percentile | FRAX 10-year probability, no treatment | RRR | |
---|---|---|---|
Estimate | 95 % CI | ||
10th | 3.4 % | 86 % | 49–96 % |
25th | 4.9 % | 85 % | 52–95 % |
50th | 8.0 % | 82 % | 54–93 % |
75th | 12.1 % | 77 % | 49–90 % |
90th | 18.4 % | 68 % | 1–90 % |